Community/Retail

Pharmacy Times® interviewed Chad Landmon, JD, of Axinn, Veltrop & Harkrider, on the arguments presented to the Supreme Court on whether a legislative change to the Affordable Care Act makes the law unconstitutional.

Are you curious about what other pharmacists earn? About the job satisfaction and compensation of pharmacists in other geographic areas? So are we!

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

In the digital age, exponential technologies are converging and transforming how we engage in health care.

Device uses an Apple Watch to deliver gentle vibrations to users suffering from post-traumatic stress disorder.

Even when all 5 factors were optimally controlled, patients with type 2 diabetes still had a 21% higher risk for CVD and a 31% higher risk for heart failure hospitalization compared to patients without diabetes.

Moderna intends to submit the EUA application today and believes that the FDA’s Vaccines and Related Biological Products Advisory Committee will meet to review the safety and efficacy data package on Thursday, December 17, according to the press release.

Patients with COVID-19 faced a significant emotional and financial burden after discharge from treatment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Smart inhalers have the potential to address the challenges faced by patients and health care professionals in the management of respiratory diseases.

Most web searches for insomnia were done between midnight and 5 am, when people are typically asleep.

According to the study results, women interested in medical cannabis reported marginally lower levels of support from their primary care provider and significantly less support from specialist physicians.

The authors noted that if regulatory agencies maintain the well-documented safety testing protocols that have been developed over the years, COVID-19 vaccines will be safe and trustworthy.

Originally approved in 2018, baloxavir marboxil is indicated for patients aged 12 years and older.

By volunteering with the American Red Cross, pharmacists can continue to help support communities who are struggling during the coronavirus disease 2019 (COVID-19) pandemic.

In the midst of a pandemic, visibility and interoperability have never been more critical when it comes to medication inventory.

The companies expect to product up to 50 million doses globally before the end of 2020, and up to 1.3 billion doses by the end of 2021.

Results from 2 pooled post-hoc analyses of phase 3 ORION-9, -10, and -11 trials evaluating inclisiran demonstrated the treatment was well-tolerated and effective.

A genetically edited form of herpes simplex virus altered to prevent it from avoiding an immune response outperformed a leading vaccine candidate.

Additional non-oral options could provide more manageable forms of PrEP treatment for patients, potentially increasing global uptake of PrEP in the future.

In the medieval period in Europe, the rise of alchemy as a field accelerated interest in the search for an elixir of life.

The NCPA and NACDS both applauded the HHS announcement regarding the partnerships with national and regional chain pharmacies and independent pharmacies to maximize access to COVID-19 vaccines.

Pharmacy Times® interviewed Maryland Secretary of Commerce Kelly M. Schulz on the economic impact of the COVID-19 pandemic on small businesses, such as community pharmacies.

Researchers find that blue light exposure should be of concern to organizations, which may be able to improve employee performance by minimizing their exposure.

The findings show that vaping changes the expression of genes and production of proteins in respiratory cells, as well as altering virus-specific antibody production, according to the study.

Those wearing a facemask while exercising may feel an increased sensation of dyspnea, however, there is little evidence that this medical condition is occurring.

The study was done in an effort to help quickly develop pharmaceutical treatments for COVID-19 by repurposing existing drugs known to effectively treat other viral diseases, according to the study authors.

Results of a recent study confirmed that patients already taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) should not discontinue taking them due to COVID-19 infection.

For patients with COVID-19, the combination of the disease and preexisting atrial arrhythmias may create a pathologic synergy that significantly increases the risk for major adverse cardiac events and death.

The research team described how approximately 12 minutes of acute cardiopulmonary exercise affected more than 80% of circulating metabolites, including pathways linked to a wide range of favorable health outcomes, thus identifying potential mechanisms that could contribute to a better understanding of the cardiometabolic benefits of exercise.